skip to Main Content

Abstract book


Thursday 22 june 2023
10.30Grand Opening
10.45 - 11.15Past Present and Future of PsychodermatologyProf. Anthony BewleyLondon (UK)
11.15 - 11.45Coffee break
11.45 - 13.15Itch
11.45 - 12.00Itch: bridging a dermatological and psychological perspective Antoinette van LaarhovenLeiden (NL)
12.00 - 12.25Chronic Itch: The dermatologist’s perspectiveProf. Elke WeisshaarHeidelberg (DE)
12.25 - 12.35Can expectations affect contagious itch? An online study on the effects of positive and negative suggestions on auditory-induced itchStefanie MeeuwisLeiden (NL)
12.35 - 12.45Can attention towards itch be changed? Preconscious attentional bias modification training in healthy individualsJennifer BeckerLeiden (NL)
12.50 - 13.00Can we use VR-assisted hypnosis for the treatment of chronic itch?Jard MattensLeiden (NL)
13.00 - 13.10Do patients with psoriasis avoid and attend to itch-related stimuli?Gita NadindaLeiden (NL)
13.15 - 14.15Lunch
14.15 - 15.45Body Dysmorphic Disorder and Psychotrichology
14.15 - 14.30Body Dysmorphic Disorder: a severe but still underrecognized disorderNienke VulinkAmsterdam (NL)
14.30 - 14.40Evaluating the outcome of cosmetic and surgical procedures in body dysmorphic disorderRida HamdiAmsterdam (NL)
14.40 - 14.50Sexuality, the ultimate ‘exposure or escape’ for patients with body dysmorphic disorder.Rieky DikmansAmsterdam (NL)
14.55 - 15.20Psychotrichology: Psychiatric and psychological aspects of hair diseaseProf. Mohammad JafferanyMichigan (US)
15.20 - 15.30Evaluation of sexual dysfunctions in patients with alopecia areataSena Inal AptoulaIstanbul (TR)
15.30 - 15.40Psychological burden in patients with cicatricial alopeciasIuliia Iu RomanovaMoscow (RU)
15.45 - 16.15Tea break
16.15 - 16.45Psycho-neuro-immunology of the skinH. Bing ThioRotterdam (NL)
16.45 - 17.00Herman Musaph Award ceremony
18.00 - 20.00Walking Dinner
Friday 23 June 2023 Room 1 Room 2
Future of Psychodermatology Technological, clinical and methodological developments09.00 - 10.30Stigmatization and Stress Session
09.00 - 09.15The use of eHealth within psychodermatologySaskia Spillekom-van KoulilNijmegen (NL)09.00 - 09.15Stigmatization and mental health burden in patients with chronic skin conditionsSylvia van BeugenLeiden (NL)
09.15 - 09.40Digital Innovations in Psychodermatology: development of a complex digital psychological intervention for adults with skin conditions Rachael HewittCardiff (UK)09.15 - 09.40Interventions Targeting Social and Self-Stigmatization Among People with Visible Chronic Skin Disease – Results from Randomized Controlled TrialsRachel SommerHamburg (DE)
09.40 - 09.50Patient-centred development and validation of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measureRachael PattinsonCardiff (UK)09.40 - 09.50Interventions to Reduce Stigmatisation of Visible Chronic Skin Disease: Results from an RCT Targeting Stigmatizing Beliefs of Body Care Professionals and a Systematic Review of Self-Stigma InterventionsJuliane TraxlerHamburg (DE)
09.50 - 10.00International Classification of Psychodermatological DisordersLadan MostaghimiWisconsin (US)09.50 - 10.00Importance of stress factors in disease activity of autoimmune bullous patientsSivaz OnurIstanbul (TR)
10.05 - 10.15Is Neutrophil Lymphocyte Ratio a promising biomarker in Psoriasis patients with Psychiatric comorbidity?Abhineetha HosthotaBangalore (IN)10.05 - 10.15Mental Health Burden Related to Patients With Vitiligo in the United KingdomProf. Andrew ThompsonCardiff (UK)
10.15 - 10.25ICD-11 – News for PsychodermatologistsMarie ZipserZurich (CH)10.15 - 10.25Stressful life events and Psychiatric comorbidity in Vitiligo-a cross sectional hospital-based case control studySwapna BondadeBangalore (IN)
10.30 - 11.00Coffee Break10.30 - 11.00Coffee Break
11.00 - 12.30Psycho-dermato-oncology11.00 - 12.30Open Communications
11.00 - 11.15Quality of life in keratinocyte carcinomaRick Waalboer-SpuijRotterdam (NL)11.00 - 11.15Words as medicine: The role of placebo effects as key for optimized dermatological careProf. Andrea EversLeiden (NL)
11.15 - 11.40Liminality and Limbo – how to help people and their families live meaningfully with the uncertainty of advanced melanomaLesley HowellsEdinburgh (UK)11.15 - 11.25Management strategies and corticophobia among healthcare professionals involved in the care for atopic dermatitis: a Dutch surveyAviël RagaminRotterdam (NL)
11.25 - 11.35Chronic prurigo and stigmatization: Results from the ESDaP study Prof. Laurent Misery Brest (FR)
11.40 - 11.50Patient experiences of resuming life after immunotherapy and associated needs regarding survivorship care: A qualitative study among patients with metastatic melanomaNadia KammingaRotterdam (NL)11.40 - 11.50Improving Screening Rates for Depression in Patients with EczemaPeiqi SuSingapore (SG)
11.50 - 12.00Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group studySven van EgmondRotterdam (NL)11.50 - 12.00Anxiety in benign and malignant skin tumours, dermatoses and controlsAnna MichenkoMoscow (RU)
12.05 - 12.15Quality of Life & Psychodermatological Management of Primary Cutaneous LymphomaAlia GaladariParis (FR)12.05 - 12.15Psychological comorbidity among women attending a vulvar clinic in Southern SwedenFlorence DalgardLund (SE)
12.15 - 12.25Psycho-oncology: The physiological explanation why chronic stress enhances cancer growth Franciso TauskRochester (US)12.15 - 12.25The Psychodermatology Diploma Courses : Present and FutureFrancoise PootBrussels (BE)
12.30 - 13.30Lunch
13.30 - 14.10Poster pitches
14.10 - 15.00Pediatric Psychodermatology
14.10 - 14.20UK Healthcare Professionals Views on Psychological Support for Children and Families Affected by Skin Conditions: A Qualitative StudyOlivia HughesCardiff (UK)
14.20 - 14.30Improvement in cardiorespiratory fitness in children and adolescents with difficult-to-treat atopic dermatitis is not related to severity of disease: which factors should be taken into account?Wieneke ZijlstraUtrecht (NL)
14.35 - 14.45Understanding the Psychosocial Needs of Paediatric Patients with Rare Birthmark Conditions: A Mixed-Methods Study to Inform the Provision of SupportElla GuestBristol (UK)
14.45 - 14.55Pediatric atopic dermatitis patients’ experiences with dupilumab injectionsTan NguyenRotterdam (NL)
15.00 - 15.30Tea break
15.30 - 16.00Psychodynamic approaches and dermatologyProf. Jorge UlnikBuenos Aires (AR)
16.00 - 17.00ESDaP General Assembly
17.00 - 18.00Drinks
Saturday 24 June 2023, Room 1 + 2 joined
09.00 - 10.00Psychopharmacological Treatment
09.00 - 09.30Psychopharmacological treatment in psychodermatology, a dermatologists perspectiveProf. Jacek SzepietowskiWroclaw (PL)
09.30 - 10.00Pharmacogenetics in psychodermatologyMieke MulderLeiden (NL)
10.00 - 10.30Coffee Break
10.30 - 12.00Psychotherapy in Psychodermatology
10.30 - 10.45How effective are psychological interventions in the treatment of chronic itchy conditions? First results of a systematic review and meta-analysisChristina SchutGiessen (DE)
10.45 - 11.10Mindfulness and self-compassion focussed approaches in facilitating adjustment to skin conditions: The story so far and future directionsProf. Andrew ThompsonCardiff (UK)
11.10 - 11.20Reducing scratching behaviour in atopic dermatitis patients using the EMDR treatment protocol for urge: a pilot studyMathijs de VeerRotterdam (NL)
11.20 - 11.30Basic Habit Reversal Therapy by dermatologists to treat body-focused repetitive behavioursJanet DuaSingapore (SG)
11.35 - 11.45Habit Reversal Success Stories from the UAEDimitre DimitrovAbu Dhabi (AE)
11.45 - 11.55Generalised Burning Skin – A Case SeriesRichard BarlowLondon (UK)
12.00 - 13.00Lunch
13.00 - 14.30Delusional Infestation
13.00 - 13.15Delusional Infestation – IntroductionPatrick KempermanAmsterdam (NL)
13.15 - 13.40Delusional Infestation – an updateProf. Peter LeppingWrexham (UK)
13.40 - 13.50Oral Ivermectin in addition to Antipsychotics offers no benefit to the management of patients with Delusional InfestationNikhil DhirLondon (UK)
13.50 - 14.00Delusions of Infestation: Retrospective case-control study and the association with prescribed stimulants for ADHDFrancisco TauskRochester (US)
14.05 - 14.15A multidisciplinary approach to ethically inform patients with delusional infestationVanessa SaradjzadaAmsterdam (NL)
14.15 - 14.25Delusional infestation (DI) in two patients with attention deficit hyperactivity disorder (ADHD) treated with lisdexamfetamine.Anna DunniganLondon (UK)
14.30 - 15.00Tea Break
15.00 - 15.30Skin diseases in children and impact on the familyProf. Suzanne PasmansRotterdam (NL)
15.30 - 16.00Award and Closing Ceremony

Our sponsors

Back To Top